About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
International Clinical Psychopharmacology
›
Top Articles
International Clinical Psychopharmacology
Psychiatry
,
Psychology
,
Pharmacology
2.2
(top 8%)
Impact Factor
2.3
(top 8%)
extended IF
94
(top 4%)
H-Index
607
authors
2.3K
papers
56.9K
citations
3.3K
citing journals
16.3K
citing authors
Most Cited Articles of International Clinical Psychopharmacology
Title
Year
Citations
The measurement of disability
1996
910
Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs)
1994
341
Depression in the community
1997
313
A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder
2012
283
Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT(2C) antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study
2002
271
Antioxidant enzyme activities and oxidative stress in affective disorders
2004
267
Efficacy of treatments for anxiety disorders: a meta-analysis
2015
250
Biological rhythm disturbances in mood disorders
2006
244
A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500)
2002
243
Assessing treatment effects in clinical trials with the discan metric of the Sheehan Disability Scale
2008
237
A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. The Venlafaxine French Inpatient Study Group
1994
216
Assessing the efficacy of treatments for panic disorder and agoraphobia. II. The Panic and Agoraphobia Scale
1995
207
Imputing response rates from means and standard deviations in meta-analyses
2005
199
Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder; a double-blind comparative study with fluvoxamine and maprotiline
1988
199
The social and economic burden of treatment-resistant schizophrenia: a systematic literature review
2014
195
Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey
2000
192
Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates
1994
190
A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables
1995
189
The GRID-HAMD: standardization of the Hamilton Depression Rating Scale
2008
179
Sexual problems in healthy and depressed persons
1998
173
Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study
2006
172
Equivalence of St John's wort extract (Ze 117) and fluoxetine: a randomized, controlled study in mild-moderate depression
2000
171
The effects of D- and L-fenfluramine (and their interactions with D-amphetamine) on psychomotor function and mood
1996
169
Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo and active-controlled trial
2007
166
Impulsive aggression and central serotonergic system function in humans: an example of a dimensional brain-behavior relationship
1992
164
previous
1999
2000
2001
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.